Fig. 4From: Intrapulmonary concentrations of meropenem administered by continuous infusion in critically ill patients with nosocomial pneumonia: a randomized pharmacokinetic trialComparison of the individual predicted AUC48–72 h and the simulated AUC48–72 h in the plasma and ELF. Comparison of the individual predicted AUC48–72 h using the Bayesian posterior estimated concentrations (red diamonds) and the simulated AUC48–72 h (black diamonds) in the plasma and ELF with two different dosages of meropenem (2 g loading dose (LD) followed by 1 g/8 h as a continuous infusion (a) and 2 g LD followed by 2 g/8 h as a continuous infusion (b))Back to article page